Mario Germano Giuliani net worth and biography

Mario Giuliani Biography and Net Worth

Director of Royalty Pharma
Mr. Mario Germano Giuliani has been the President and Chief Executive Officer of Giuliani SpA. He has been the President at the firm since 2003 and Chief Executive Officer since 2000. Mr. Giuliani served as Chief Financial Officer of Giuliani SpA from 1999-2000.

From January 1998 to January 1999, Mr. Giuliani was an investment professional atVector Fund Management. He also co-founded Mosaix Ventures LP, in 2000. He also served at Giuliani SpA, Italy from 1996-1997 responsible for Marketing, Sales, Finance and Controlling. He is a Member of the Board of Directors of HBM Healthcare Investments AG. He also serves on several private company boards. He is a Director of Royalty Pharma since 2001. He served at Recordati SpA as Member of the Board of Directors since 2011.
Mr. Giuliani holds a degree in Economy and Commerce from the Catholic University of Sacred Heart and a Masters in Corporate Finance from Universit Commerciale Luigi Bocconi in Milan, Italy.

What is Mario Germano Giuliani's net worth?

The estimated net worth of Mario Germano Giuliani is at least $344.74 million as of September 21st, 2022. Mr. Giuliani owns 8,321,113 shares of Royalty Pharma stock worth more than $344,743,712 as of September 28th. This net worth evaluation does not reflect any other assets that Mr. Giuliani may own. Learn More about Mario Germano Giuliani's net worth.

How do I contact Mario Germano Giuliani?

The corporate mailing address for Mr. Giuliani and other Royalty Pharma executives is 110 E 59th Street, New York NY, 10022. Royalty Pharma can also be reached via phone at 212-883-0200 and via email at [email protected] Learn More on Mario Germano Giuliani's contact information.

Has Mario Germano Giuliani been buying or selling shares of Royalty Pharma?

Within the last three months, Mario Germano Giuliani has sold $32,480,538.13 in Royalty Pharma stock. Most recently, Mario Germano Giuliani sold 125,697 shares of the business's stock in a transaction on Wednesday, September 21st. The shares were sold at an average price of $41.25, for a transaction totalling $5,185,001.25. Following the completion of the sale, the director now directly owns 8,321,113 shares of the company's stock, valued at $343,245,911.25. Learn More on Mario Germano Giuliani's trading history.

Who are Royalty Pharma's active insiders?

Royalty Pharma's insider roster includes Terrance Coyne (CFO), Henry Fernandez (Director), William Ford (Director), Mario Giuliani (Director), Pablo Legorreta (CEO), George Lloyd (EVP), James Reddoch (EVP), Rory Riggs (Director), Sanjay Singh (CRO), and Marshall Urist (EVP). Learn More on Royalty Pharma's active insiders.

Are insiders buying or selling shares of Royalty Pharma?

In the last twelve months, Royalty Pharma insiders bought shares 1 times. They purchased a total of 32,500 shares worth more than $1,218,425.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 30 times. They sold a total of 2,686,447 shares worth more than $111,494,739.43. The most recent insider tranaction occured on September, 21st when Director Mario Germano Giuliani sold 125,697 shares worth more than $5,185,001.25. Insiders at Royalty Pharma own 24.9 % of the company. Learn More about insider trades at Royalty Pharma.

Information on this page was last updated on 9/21/2022.

Mario Germano Giuliani Insider Trading History at Royalty Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/21/2022Sell125,697$41.25$5,185,001.258,321,113View SEC Filing Icon  
9/19/2022Sell232,185$41.50$9,635,677.5022,657,815View SEC Filing Icon  
9/16/2022Sell154,986$41.72$6,466,015.9222,890,000View SEC Filing Icon  
9/7/2022Sell261,881$42.66$11,171,843.468,814,759View SEC Filing Icon  
8/25/2022Sell500$44.00$22,000.009,076,640View SEC Filing Icon  
See Full Table

Mario Germano Giuliani Buying and Selling Activity at Royalty Pharma

This chart shows Mario Germano Giuliani's buying and selling at Royalty Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Royalty Pharma Company Overview

Royalty Pharma logo
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Read More

Today's Range

Now: $41.19
Low: $40.97
High: $41.71

50 Day Range

MA: $42.74
Low: $39.88
High: $44.65

2 Week Range

Now: $41.19
Low: $34.86
High: $44.75

Volume

116,375 shs

Average Volume

1,762,657 shs

Market Capitalization

$25.01 billion

P/E Ratio

53.49

Dividend Yield

1.91%

Beta

0.3